ACAD
30.46
-0.59
-1.90%
AEMD
0.25
0.00
-1.19%
APRI
1.39
-0.04
-2.80%
ARNA
4.32
-0.2
-4.32%
ATEC
1.29
-0.02
-1.53%
CFN
59.33
-0.28
-0.46%
CNAT
5.82
-0.14
-2.35%
CRXM
0.21
0.00
-1.38%
CYTX
0.48
+0.01
+1.89%
DXCM
59.81
-1.19
-1.95%
GNMK
12.89
-0.42
-3.16%
HALO
14.29
-0.3
-2.06%
ILMN
195.68
-4.32
-2.16%
INNV
0.22
+0.01
+4.19%
INO
8.33
-0.17
-2.00%
ISCO
0.06
0.00
0.00%
ISIS
68.56
-1.3
-1.86%
LGND
56.43
-0.6
-1.05%
LPTN
2.76
-0.09
-3.16%
MBVX
1.04
-0.01
-0.95%
MEIP
3.98
+0.12
+3.11%
MNOV
3.79
+0.02
+0.53%
MRTX
20.67
-0.62
-2.91%
MSTX
0.45
+0.01
+3.37%
NBIX
33.71
-0.64
-1.86%
NUVA
46.31
-0.99
-2.09%
ONCS
0.36
-0.01
-2.74%
ONVO
6.41
-0.28
-4.19%
OREX
5.26
-0.1
-1.78%
OTIC
29.25
-2.32
-7.35%
QDEL
23.53
-0.94
-3.84%
RCPT
110.06
-2.65
-2.35%
RGLS
19.15
+0.57
+3.04%
RMD
62.52
-0.51
-0.81%
SCIE
0.01
0.00
-2.65%
SPHS
0.48
+0.01
+1.34%
SRNE
10.1
-0.68
-6.31%
TROV
6.48
+0.65
+11.17%
VICL
1.03
-0.01
-0.96%
VOLC
17.96
0.00
0.00%
ZGNX
1.36
-0.01
-0.74%
Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

How Should the Innovation Community Solve Its Gender and Diversity Problems?

January 5, 2015 – 1:00 am | Edit Post
How Should the Innovation Community Solve Its Gender and Diversity Problems?

It’s been one of the hottest-button topics of the past year—and it’s not going away anytime soon. The under-representation of women and minorities in technology and innovation jobs…

[[Click headline to continue reading.]]

How Should the Innovation Community Solve Its Gender and Diversity Problems?

January 5, 2015 – 1:00 am | Edit Post

It’s been one of the hottest-button topics of the past year—and it’s not going away anytime soon. The under-representation of women and minorities in technology and innovation jobs…

[[Click headline to continue reading.]]

Isis Pharmaceuticals, Inc. Rockets as Johnson & Johnson Snags Bowel Drug License Option for $835 Million

January 4, 2015 – 5:00 pm | Edit Post

Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract– Collaboration Combines Isis’ RNA-Targeted Technology With Expertise of Janssen in Autoimmune Disorders and Therapeutic Formulation –CARLSBAD…

Celladon Corporation Conducts Initial Scale Up Of Manufacturing Process For MYDICAR To Commercial Scale

January 4, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 5, 2015 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that it has conducted initial scale up of its viral manufacturing process for MYDICAR…

Working To Unlock Syndrome, University of California, San Diego (UCSD) Reveals

January 4, 2015 – 5:00 pm | Edit Post

Engineering students in California have spent the last three months trying to create a new way for a mute, paralyzed Naugatuck man to communicate. Since October, graduate and undergraduate students at the University of California-San Diego have been experimenting with sensors, software and wireless devices that might allow Bob Veillette, stricken with Locked-In Syndrome eight years ago, to communicate…

SoCal’s GlySens Incorporated Locks in $12 Million

January 4, 2015 – 5:00 pm | Edit Post

GlySens Incorporated Secures $12M Series C InvestmentProceeds dedicated to advanced product commercialization stepsSAN DIEGO, Jan. 5, 2015 /PRNewswire/ — GlySens Incorporated announced today that it has closed a $12 million dollar…

Conatus Pharmaceuticals Inc. To Report Top-Line Results From ACLF And Organ Impairment Clinical Trials Of Emricasan

January 4, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 5, 2015 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will report top-line results from three clinical trials in subjects with…

Kevin Sayer Assumes Role of President and Chief Executive Officer; <b>Terry Gregg</b> Transitions to Role of Executive Chairman

January 4, 2015 – 5:00 pm | Edit Post

Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive ChairmanSAN DIEGO–(BUSINESS WIRE)– DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, currently the Company’s President and Chief Operating Officer, has assumed the role of President and Chief Executive Officer to succeed Terry Gregg, who…

DexCom Release: Assumes Role of President and Chief Executive Officer; Transitions to Role of Executive Chairman

January 4, 2015 – 5:00 pm | Edit Post

Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive ChairmanSAN DIEGO–(BUSINESS WIRE)– DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, currently the Company’s President and Chief Operating Officer, has assumed the role of President and Chief Executive Officer to succeed Terry Gregg, who…

Imprimis Pharmaceuticals Appoints To Its Board Of Directors

January 4, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 5, 2015 /PRNewswire/ –Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, today announced the appointment of internationally-renowned ophthalmologist, Richard…